Evidence map›Paper›PMID 19945261›Full record

ArticleArtificial intelligence in medicine

An MLP-based feature subset selection for HIV-1 protease cleavage site analysis.

Gilhan Kim, Yeonjoo Kim, Heuiseok Lim, Hyeoncheol Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Artificial intelligence in medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gilhan KimDepartment of Computer Science Education, Korea University, Seoul 136-701, Republic of Korea.
Yeonjoo Kim
Heuiseok Lim
Hyeoncheol Kim
Korea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn recent years, several machine learning approaches have been applied to modeling the specificity of the human immunodeficiency virus type 1 (HIV-1) protease cleavage domain. However, the high dimensional domain dataset contains a small number of samples, which could misguide classification modeling and its interpretation. Appropriate feature selection can alleviate the problem by eliminating irrelevant and redundant features, and thus improve prediction performance.

methodsWe introduce a new feature subset selection method, FS-MLP, that selects relevant features using multi-layered perceptron (MLP) learning. The method includes MLP learning with a training dataset and then feature subset selection using decompositional approach to analyze the trained MLP. Our method is able to select a subset of relevant features in high dimensional, multi-variate and non-linear domains.

resultsUsing five artificial datasets that represent four data types, we verified the FS-MLP performance with seven other feature selection methods. Experimental results showed that the FS-MLP is superior at high dimensional, multi-variate and non-linear domains. In experiments with HIV-1 protease cleavage dataset, the FS-MLP selected a set of 14 highly relevant features among 160 original features. On a validation set of 131 test instances, classifiers that used the 14 features showed about 95% accuracy which outperformed other seven methods in terms of accuracy and the number of features.

conclusionsOur experimental results indicate that the FS-MLP is effective in analyzing multi-variate, non-linear and high dimensional datasets such as HIV-1 protease cleavage dataset. The 14 relevant features which were selected by the FS-MLP provide us with useful insights into the HIV-1 cleavage site domain as well. The FS-MLP is a useful method for computational sequence analysis in general.

Indexed as

Artificial IntelligenceModels, MolecularSystems BiologySystems IntegrationComputer SimulationDatabases, ProteinData MiningHIV ProteaseNonlinear DynamicsProtein ConformationProtein Structure, TertiaryReproducibility of ResultsStructure-Activity RelationshipSubstrate SpecificityHIV Proteasep16 protease, Human immunodeficiency virus 1

Identifiers

PMID19945261
OpenAlexW1994329895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.